Research Institute of Molecular Pathology
Template: Infobox university / student missing template: Infobox university / staff missing template: Infobox university / professors missing
The Research Institute of Molecular Pathology ( Institute of Molecular Pathology, IMP) is a private non-profit research institute for Molecular Biology in Vienna. The Institute is headed by Jan- Michael Peters. The previous directors were Barry J. Dickson, Kim Nasmyth and Max Birnstiel.
The IMP was founded in 1985 as a joint venture between the international pharmaceutical company Boehringer Ingelheim and the U.S. biotechnology company Genentech. After the founding of IMP originated in the district of Sankt Marx ( in the district of Landstraße) other research institutions, companies and training programs that make up the Campus Vienna Biocenter.
The IMP conducts basic research in the fields of cell biology, neuroscience and molecular medicine. With the help of suitable model systems to basic biological processes in healthy and diseased organism are studied. The IMP provides it to places for PhD students and postdoctoral fellows. The research results are published in scientific journals. The rights for the commercial exploitation of patents or for any further development of therapeutically relevant substances are at Boehringer Ingelheim, which since 1993 has been the sole shareholder of the IMP.
The IMP includes major research departments under the direction of " senior scientists ", smaller working groups, is responsible for each of which a " group leader ", and an independent Fellowship position. The research groups are supplemented by eight service departments.
Awards (selection)
IMP scientists were awarded several scientific prizes.
- Wittgenstein Prize: 1996 Erwin Friedrich Wagner, 1999 Ashley Kim Nasmyth, 2001 Meinrad Busslinger, 2011 Jan- Michael Peters
- Erwin Schrödinger Prize: 2007 Thomas Jenuwein
- Wilhelm Exner Medal: 1994 Max Birnstiel
- Max Planck Research Award: 1993 Erwin F. Wagner
- Start Price: 2013 David A. Keays